Peripheral oxidative damage in early-stage mood disorders: A nested population-based case-control study

International Journal of Neuropsychopharmacology

Volumn 15, Issue 8, 2012, Pages 1043-1050

  Magalhães, Pedro V S ^a   Jansen, Karen ^b   Pinheiro, Ricardo Tavares ^b   Colpo, Gabriela Delevati ^a,c   Da Motta, Leonardo Lisbôa ^c   Klamt, Fábio ^c   Da Silva, Ricardo Azevedo ^b   Kapczinski, Flávio ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b CATHOLIC UNIVERSITY OF PELOTAS   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Bipolar disorder; major depression; oxidative stress; population based study; protein carbonyl content; thiobarbituric acid reactive substances

Indexed keywords

PROTEIN; PROTEIN CARBONYL; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIPOLAR DISORDER; CASE CONTROL STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PSYCHOLOGIC TEST;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; COMMUNITY HEALTH PLANNING; FEMALE; HUMANS; MALE; MOOD DISORDERS; OXIDATIVE STRESS; PROTEIN CARBONYLATION; PSYCHIATRIC STATUS RATING SCALES; THIOBARBITURIC ACID REACTIVE SUBSTANCES; YOUNG ADULT;

EID: 84864565916     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145711001532     Document Type: Article

References (59)

1. ABEP (2003). Associaçäo Brasileira de Empresas de Pesquisa (http://www.abep.org.br). Accessed May 2008.
2. Aldini G, Dalle-Donne I, Facino RM, Milzani A, et al. (2007). Intervention strategies to inhibit protein carbonylation by lipoxidation-derived reactive carbonyls. Medicinal Research Reviews 27, 817-868.
3. Andreazza AC, Frey BN, Erdtmann B, Salvador M, et al. (2007). DNA damage in bipolar disorder. Psychiatry Research 153, 27-32.
4. Andreazza AC, Kapczinski F, Kauer-Sant'Anna M, Walz JC, et al. (2009). 3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder. Journal of Psychiatry and Neuroscience 34, 263-271.
5. Andreazza AC, Kauer-Sant'Anna M, Frey BN, Bond DJ, et al. (2008). Oxidative stress markers in bipolar disorder: a meta-analysis. Journal of Affective Disorders 111, 135-144.
6. Andreazza AC, Shao L, Wang JF, Young LT (2010). Mitochondrial complex i activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Archives of General Psychiatry 67, 360-368.
7. Babyak MA (2004). What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosomatic Medicine 66, 411-421.
8. Berk M (2009). Neuroprogression: pathways to progressive brain changes in bipolar disorder. International Journal of Neuropsychopharmacology 12, 441-445.
9. Berk M, Conus P, Kapczinski F, Andreazza AC, et al. (2010). From neuroprogression to neuroprotection: implications for clinical care. Medical Journal of Australia 193, S36-S40.
10. Berk M, Dodd S, Kauer-Sant'Anna M, Malhi GS, et al. (2007). Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder. Acta Psychiatrica Scandinavica 116, 41-49.
11. Berk M, Kapczinski F, Andreazza AC, Dean OM, et al. (2011). Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neuroscience and Biobehavioral Reviews 35, 804-817.
12. Berk M, Malhi GS, Hallam K, Gama CS, et al. (2009). Early intervention in bipolar disorders: clinical, biochemical and neuroimaging imperatives. Journal of Affective Disorders 114, 1-13.
13. Cataldo AM, McPhie DL, Lange NT, Punzell S, et al. (2010). Abnormalities in mitochondrial structure in cells from patients with bipolar disorder. American Journal of Pathology 177, 575-585.
14. Chaudhary M, Rao PV (2010). Brain oxidative stress after dermal and subcutaneous exposure of T-2 toxin in mice. Food and Chemical Toxicology 48, 3436-3442.
15. Chen G, Henter ID, Manji HK (2010). Translational research in bipolar disorder: emerging insights from genetically based models. Molecular Psychiatry 15, 883-895.
16. da Rocha RF, de Oliveira MR, Schonhofen P, De Bastiani MA, et al. (2010). Vitamin A supplementation for different periods alters rat vascular redox parameters. Journal of Physiology and Biochemistry 66, 351-357.
17. Dalle-Donne I, Rossi R, Giustarini D, Milzani A, et al. (2003). Protein carbonyl groups as biomarkers of oxidative stress. Clinica Chimica Acta 329, 23-38.
18. Draper HH, Hadley M (1990). Malondialdehyde determination as index of lipid peroxidation. Methods in Enzymology 186, 421-431.
19. Frey BN, Valvassori SS, Gomes KM, Martins MR, et al. (2006). Increased oxidative stress in submitochondrial particles after chronic amphetamine exposure. Brain Research 1097, 224-229.
20. Gianaros PJ, Manuck SB (2010). Neurobiological pathways linking socioeconomic position and health. Psychosomatic Medicine 72, 450-461.
21. Gigante AD, Young LT, Yatham LN, Andreazza AC, et al. (2010). Morphometric post-mortem studies in bipolar disorder: possible association with oxidative stress and apoptosis. International Journal of Neuropsychopharmacology 14, 1075-1089.
22. Gilgun-Sherki Y, Melamed E, Offen D (2001). Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. Neuropharmacology 40, 959-975.
23. Giustarini D, Dalle-Donne I, Tsikas D, Rossi R (2009). Oxidative stress and human diseases: origin, link, measurement, mechanisms, and biomarkers. Critical Reviews in Clinical Laboratory Sciences 46, 241-281.
24. Hackman DA, Farah MJ, Meaney MJ (2010). Socioeconomic status and the brain: mechanistic insights from human and animal research. Nature Reviews Neuroscience 11, 651-659.
25. Halliwell B, Chirico S (1993). Lipid peroxidation: its mechanism, measurement, and significance. American Journal of Clinical Nutrition 57 (Suppl. 5), 715S-724S, discussion 724S-725S.
26. Harrell FE, Lee KL, Mark DB (1996). Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Statistics in Medicine 15, 361-387.
27. Henderson AR (2005). The bootstrap: a technique for data-driven statistics. Using computer-intensive analyses to explore experimental data. Clinica Chimica Acta 359, 1-26.
28. Henrique I, De Micheli D, Lacerda R, Lacerda L, et al. (2004). Validation of the Brazilian Version of Alcohol, Smoking and Substance Involvement Screening Test (ASSIST). Revista da Associacao Medica Brasileira 50, 199-206.
29. Jansen K, Ores Lda C, Cardoso Tde A, Lima Rda C, et al. (2011). Prevalence of episodes of mania and hypomania and associated comorbidities among young adults. Journal of Affective Disorders 130, 328-333.
30. Juster RP, McEwen BS, Lupien SJ (2010). Allostatic load biomarkers of chronic stress and impact on health and cognition. Neuroscience and Biobehavioral Reviews 35, 2-16.
31. Kapczinski F, Dal-Pizzol F, Teixeira AL, Magalhaes PVS, et al. (2011). Peripheral biomarkers and illness activity in bipolar disorder. Journal of Psychiatric Research 45, 156-161.
32. Kapczinski F, Dal-Pizzol F, Teixeira AL, Magalhaes PVS, et al. (2010). A systemic toxicity index developed to assess peripheral changes in mood episodes. Molecular Psychiatry 15, 784-786.
33. Kapczinski F, Vieta E, Andreazza AC, Frey BN, et al. (2008). Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neuroscience and Biobehavioral Reviews 32, 675-692.
34. Kato T, Kato N (2000). Mitochondrial dysfunction in bipolar disorder. Bipolar Disorders 2, 180-190.
35. Kauer-Sant'Anna M, Kapczinski F, Andreazza AC, Bond DJ, et al. (2009). Brain-derived neurotrophic factor and inflammatory markers in patients with early-vs. late-stage bipolar disorder. International Journal of Neuropsychopharmacology 12, 447-458.
36. Kupfer DJ (2005). The increasing medical burden in bipolar disorder. Journal of the American Medical Association 293, 2528-2530.
37. Levine RL, Garland D, Oliver CN, Amici A, et al. (1990). Determination of carbonyl content in oxidatively modified proteins. Methods in Enzymology 186, 464-478.
38. Machado-Vieira R, Andreazza AC, Viale CI, Zanatto V, et al. (2007). Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects. Neuroscience Letters 421, 33-36.
39. Maes M, Galecki P, Chang YS, Berk M (2010a). A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Progress in Neuropsychopharmacology and Biological Psychiatry 35, 676-692.
40. Maes M, Mihaylova I, Kubera M, Uytterhoeven M, et al. (2010b). Increased plasma peroxides and serum oxidized low density lipoprotein antibodies in major depression: markers that further explain the higher incidence of neurodegeneration and coronary artery disease. Journal of Affective Disorders 125, 287-294.
41. Magalhaes PV, Jansen K, Pinheiro RT, Klamt F, et al. (2011). Systemic toxicity in early-stage mood disorders. Journal of Psychiatric Research 45, 1407-1409.
42. McDade TW, Williams S, Snodgrass JJ (2007). What a drop can do: dried blood spots as a minimally invasive method for integrating biomarkers into population-based research. Demography 44, 899-925.
43. McEwen BS (2003). Mood disorders and allostatic load. Biological Psychiatry 54, 200-207.
44. McEwen BS, Gianaros PJ (2011). Stress-and allostasisinduced brain plasticity. Annual Review of Medicine 62, 431-445.
45. Morgan PE, Sturgess AD, Davies MJ (2009). Evidence for chronically elevated serum protein oxidation in systemic lupus erythematosus patients. Free Radical Research 43, 117-127.
46. Ng F, Berk M, Dean O, Bush AI (2008). Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. International Journal of Neuropsychopharmacology 11, 851-876.
47. Oliveira MW, Minotto JB, de Oliveira MR, Zanotto-Filho A, et al. (2010). Scavenging and antioxidant potential of physiological taurine concentrations against different reactive oxygen/nitrogen species. Pharmacological Reports 62, 185-193.
48. Ortona E, Margutti P, Matarrese P, Franconi F, et al. (2008). Redox state, cell death and autoimmune diseases: a gender perspective. Autoimmunity Reviews 7, 579-584.
49. Ozcan ME, Gulec M, Ozerol E, Polat R, et al. (2004). Antioxidant enzyme activities and oxidative stress in affective disorders. International Clinical Psychopharmacology 19, 89-95.
50. Pasquali MA, Schnorr CE, Feistauer LB, Gelain DP, et al. (2010). Vitamin A supplementation to pregnant 'and breastfeeding female rats induces oxidative stress in the neonatal lung. Reproductive Toxicology 30, 452-456.
51. Rosemberg DB, da Rocha RF, Rico EP, Zanotto-Filho A, et al. (2010). Taurine prevents enhancement of acetylcholinesterase activity induced by acute ethanol exposure and decreases the level of markers of oxidative stress in zebrafish brain. Neuroscience 171, 683-692.
52. Schwedhelm E, Maas R, Troost R, Boger RH (2003). Clinical pharmacokinetics of antioxidants and their impact on systemic oxidative stress. Clinical Pharmacokinetics 42, 437-459.
53. Sedlak TW, Saleh M, Higginson DS, Paul BD, et al. (2009). Bilirubin and glutathione have complementary antioxidant and cytoprotective roles. Proceedings of the National Academy of Sciences USA 106, 5171-5176.
54. Semba RD, Ferrucci L, Sun K, Walston J, et al. (2007). Oxidative stress is associated with greater mortality in older women living in the community. Journal of the American Geriatrics Society 55, 1421-1425.
55. Sheehan DV, Janavs J, Baker R, Harnett-Sheehan K, et al. (1998). MINI-mini international neuropsychiatric interview-English Version 5.0.0-DSM-IV. Journal of Clinical Psychiatry 59, 34-57.
56. Valvassori SS, Rezin GT, Ferreira CL, Moretti M, et al. (2010). Effects of mood stabilizers on mitochondrial respiratory chain activity in brain of rats treated with D-amphetamine. Journal of Psychiatric Research 44, 903-909.
57. Wills ED (1966). Mechanisms of lipid peroxide formation in animal tissues. Biochemical Journal 99, 667-676.
58. Yamamoto BK, Raudensky J (2008). The role of oxidative stress, metabolic compromise, and inflammation in neuronal injury produced by amphetamine-related drugs of abuse. Journal of Neuroimmune Pharmacology 3, 203-217.
59. Yeh CC, Lai CY, Hsieh LL, Tang RP, et al. (2010). Protein carbonyl levels, glutathione S-transferase polymorphisms and risk of colorectal cancer. Carcinogenesis 31, 228-233.